Published in Clin Chem on March 11, 2005
Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr (2008) 0.77
Diurnal triglyceridemia in relation to alcohol intake in men. Nutrients (2013) 0.75
Coronary risk factors and metabolic disorders in first-degree relatives of normocholesterolaemic patients with premature atherosclerosis. Neth Heart J (2006) 0.75
Dyslipidemia in obesity: mechanisms and potential targets. Nutrients (2013) 2.02
Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol (2006) 1.99
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood (2013) 1.65
Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. Biol Blood Marrow Transplant (2012) 1.59
APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis (2009) 1.56
FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS One (2013) 1.52
[Factors influencing incipient diabetic nephropathy: ESODIAH study]. Med Clin (Barc) (2005) 1.38
Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care (2003) 1.26
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial. Ann Intern Med (2005) 1.19
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variation. Clin Chem (2006) 1.16
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine. AIDS (2002) 1.15
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res (2008) 1.11
Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem (2002) 1.11
Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol (2012) 1.08
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. J Clin Oncol (2013) 1.07
Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients. AIDS (2004) 1.04
Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem (2007) 1.02
The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients. Pharmacogenet Genomics (2013) 1.02
Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens. Clin Infect Dis (2010) 1.00
The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J Infect Dis (2011) 0.99
Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. J Rheumatol (2002) 0.97
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17). J Clin Oncol (2013) 0.96
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med (2011) 0.95
PTX3 deficiency and aspergillosis. N Engl J Med (2014) 0.95
The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis (2006) 0.95
Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis (2010) 0.93
Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia. Atherosclerosis (2009) 0.92
Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation. PLoS One (2011) 0.91
Alcohol and plasma triglycerides. Curr Opin Lipidol (2013) 0.91
A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL. Blood (2010) 0.90
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis (2012) 0.88
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis (2007) 0.88
Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension. PLoS One (2012) 0.88
Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr (2010) 0.88
Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem (2009) 0.87
Prevalence of and predictors of bicuspid aortic valves in patients with dilated aortic roots. Am J Cardiol (2003) 0.87
FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res (2010) 0.87
Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life (2008) 0.86
Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis. J Rheumatol (2008) 0.85
Small artery dilation and endothelial markers in cardiovascular risk patients. Eur J Clin Invest (2011) 0.85
Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy. PLoS One (2013) 0.84
Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients. Clin Exp Pharmacol Physiol (2006) 0.84
Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines. J Immunother (2012) 0.84
Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy. Br J Clin Pharmacol (2010) 0.84
Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy. Antimicrob Agents Chemother (2011) 0.84
Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy. Antimicrob Agents Chemother (2012) 0.84
Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages. Atherosclerosis (2002) 0.84
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. Int J Radiat Oncol Biol Phys (2011) 0.84
Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation. J Lipid Res (2007) 0.83
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr (2005) 0.83
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. J Cancer Res Clin Oncol (2010) 0.83
The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients. Clin Chem Lab Med (2008) 0.83
Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy? Cancer Sci (2010) 0.82
Systemic inflammation and lung function impairment in morbidly obese subjects with the metabolic syndrome. J Obes (2013) 0.82
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial. PLoS One (2012) 0.81
Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am J Clin Nutr (2007) 0.81
Retinoic acid induces PGI synthase expression in human endothelial cells. J Lipid Res (2008) 0.81
Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients. PLoS One (2013) 0.81
Daytime triglyceridemia in normocholesterolemic patients with premature atherosclerosis and in their first-degree relatives. Metabolism (2004) 0.81
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females. J Clin Oncol (2008) 0.80
Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol. Clin Chem Lab Med (2007) 0.80
HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages. Biochim Biophys Acta (2003) 0.80
Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis. Drugs (2004) 0.80
The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects. Clin Chem Lab Med (2003) 0.80
Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy. Anal Bioanal Chem (2012) 0.79
Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients. Cardiovasc Diabetol (2013) 0.79
Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release. Dig Dis Sci (2004) 0.79
Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation. Haematologica (2013) 0.79
Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol (2010) 0.78
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice. Eur J Clin Invest (2012) 0.78
Erythrocyte-bound apolipoprotein B in relation to atherosclerosis, serum lipids and ABO blood group. PLoS One (2013) 0.78
Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients. Antivir Ther (2012) 0.78
Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol Endocrinol (2011) 0.77
Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment. Sleep (2013) 0.77
Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages. Atherosclerosis (2013) 0.77
Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy. Arterioscler Thromb Vasc Biol (2010) 0.77
[Micronutrients in HIV-infection and the relationship with the inflammatory response]. Med Clin (Barc) (2002) 0.77
Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II). Mol Cell Probes (2003) 0.77
Bronchial and systemic inflammation in morbidly obese subjects with asthma: a biopsy study. Am J Respir Crit Care Med (2014) 0.76
Cytotoxic effects of the lipid peroxidation product 2,4-decadienal in vascular smooth muscle cells. Atherosclerosis (2003) 0.76
Even low physical activity levels improve vascular function in overweight and obese postmenopausal women. Menopause (2013) 0.76
Aldehydes mediate tissue factor induction: a possible mechanism linking lipid peroxidation to thrombotic events. J Cell Physiol (2004) 0.76
Horse versus rabbit antithymocyte globulin in aplastic anemia. N Engl J Med (2011) 0.75
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response. J Clin Invest (2017) 0.75
Correction: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway. PLoS One (2016) 0.75
Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin. Atherosclerosis (2010) 0.75
[Cholesterol homeostasis and enterohepatic connection: new insights in cholesterol absorption]. Ned Tijdschr Geneeskd (2011) 0.75
[Which cardiovascular risk tables should we use?]. Rev Esp Cardiol (2007) 0.75
Satisfaction With Methadone and Opioid Receptor Genes Polymorphisms in Treatment-Refractory Heroin-Dependent Patients. J Clin Psychopharmacol (2017) 0.75
Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit. Clin Chem Lab Med (2004) 0.75
Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk. Rev Esp Cardiol (Engl Ed) (2011) 0.75